1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-care Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genetic Screening
1.2.3 Image Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global Point-of-care Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-care Cancer Screening Market Perspective (2018-2029)
2.2 Point-of-care Cancer Screening Growth Trends by Region
2.2.1 Global Point-of-care Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point-of-care Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Point-of-care Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Point-of-care Cancer Screening Market Dynamics
2.3.1 Point-of-care Cancer Screening Industry Trends
2.3.2 Point-of-care Cancer Screening Market Drivers
2.3.3 Point-of-care Cancer Screening Market Challenges
2.3.4 Point-of-care Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-care Cancer Screening Players by Revenue
3.1.1 Global Top Point-of-care Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Point-of-care Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Point-of-care Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point-of-care Cancer Screening Revenue
3.4 Global Point-of-care Cancer Screening Market Concentration Ratio
3.4.1 Global Point-of-care Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-care Cancer Screening Revenue in 2022
3.5 Point-of-care Cancer Screening Key Players Head office and Area Served
3.6 Key Players Point-of-care Cancer Screening Product Solution and Service
3.7 Date of Enter into Point-of-care Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-care Cancer Screening Breakdown Data by Type
4.1 Global Point-of-care Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Point-of-care Cancer Screening Forecasted Market Size by Type (2024-2029)
5 Point-of-care Cancer Screening Breakdown Data by Application
5.1 Global Point-of-care Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Point-of-care Cancer Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point-of-care Cancer Screening Market Size (2018-2029)
6.2 North America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point-of-care Cancer Screening Market Size by Country (2018-2023)
6.4 North America Point-of-care Cancer Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-care Cancer Screening Market Size (2018-2029)
7.2 Europe Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point-of-care Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Point-of-care Cancer Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-care Cancer Screening Market Size (2018-2029)
8.2 Asia-Pacific Point-of-care Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Point-of-care Cancer Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-care Cancer Screening Market Size (2018-2029)
9.2 Latin America Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point-of-care Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Point-of-care Cancer Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-care Cancer Screening Market Size (2018-2029)
10.2 Middle East & Africa Point-of-care Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Point-of-care Cancer Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hologic Corporation
11.1.1 Hologic Corporation Company Detail
11.1.2 Hologic Corporation Business Overview
11.1.3 Hologic Corporation Point-of-care Cancer Screening Introduction
11.1.4 Hologic Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.1.5 Hologic Corporation Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Point-of-care Cancer Screening Introduction
11.2.4 Abbott Laboratories Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Qiagen N.V.
11.3.1 Qiagen N.V. Company Detail
11.3.2 Qiagen N.V. Business Overview
11.3.3 Qiagen N.V. Point-of-care Cancer Screening Introduction
11.3.4 Qiagen N.V. Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.3.5 Qiagen N.V. Recent Development
11.4 F Hoffmann-La Roche
11.4.1 F Hoffmann-La Roche Company Detail
11.4.2 F Hoffmann-La Roche Business Overview
11.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Introduction
11.4.4 F Hoffmann-La Roche Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.4.5 F Hoffmann-La Roche Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Point-of-care Cancer Screening Introduction
11.5.4 BD Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.5.5 BD Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Detail
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Point-of-care Cancer Screening Introduction
11.6.4 Quest Diagnostics Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.6.5 Quest Diagnostics Recent Development
11.7 OncoHealth Corp
11.7.1 OncoHealth Corp Company Detail
11.7.2 OncoHealth Corp Business Overview
11.7.3 OncoHealth Corp Point-of-care Cancer Screening Introduction
11.7.4 OncoHealth Corp Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.7.5 OncoHealth Corp Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Point-of-care Cancer Screening Introduction
11.8.4 Danaher Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 NOVIGENIX SA
11.9.1 NOVIGENIX SA Company Detail
11.9.2 NOVIGENIX SA Business Overview
11.9.3 NOVIGENIX SA Point-of-care Cancer Screening Introduction
11.9.4 NOVIGENIX SA Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.9.5 NOVIGENIX SA Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Point-of-care Cancer Screening Introduction
11.10.4 Quidel Corporation Revenue in Point-of-care Cancer Screening Business (2018-2023)
11.10.5 Quidel Corporation Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
